Tokyo, Aug. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058795) titled 'Preventive Acupuncture Using Multi-Core Thumbtack Needles at PC6 (Neiguan) for VR Sickness' on Aug. 20.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Teikyo Heisei University
Condition:
Condition - Virtual Reality Sickness
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effectiveness of preventive acupuncture therapy using multi-core thumbtack needles at PC6 (Neiguan) as a symptomatic treatment for virtual reality (VR) sickness, a condition that currently lacks a fundamental solution.
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - Control Group: Received a sham (placebo) needle
Interventions/Control_2 - Intervention Group: Received a multi-core thumbtack needle
Eligibility:
Age-lower limit - 18
years-old
Gender - Male
Key inclusion criteria - Individuals who have experienced, or have a history of, VR sickness or motion sickness.
Key exclusion criteria - Individuals with underlying medical conditions (particularly Meniere's disease or vestibular migraine).
Target Size - 88
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 02 Day
Date of IRB - 2025 Year 07 Month 02 Day
Anticipated trial start date - 2025 Year 08 Month 20 Day
Last follow-up date - 2026 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067229
Disclaimer: Curated by HT Syndication.
